GeoVax to Participate in International Webinar Focused on the State of COVID-19 Vaccines

by NASDAQ Market News June 29, 2020

NASDAQ Market News
Click here to email author

PM360 Now Accepting Entries for 2020 Pharma Choice Awards

Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 450 Million Data Points, Ahead of Schedule, and Accelerates the Company’s Path to 1 Billion Data Points Curated Specifically for Oncology Drug Development and Drug Response Prediction

Ads